Skip to main content

Chris Kendrick-Parker, John Stuelpnagel, Christian Henry, David Smith

Chris Kendrick-Parker has been named to GenTel Biosciences’ board of directors, the firm said last week.
Kendrick-Parker previously served as vice president at Affymetrix where he managed sales and marketing for its global pharma business unit. Prior to that, he served on Amersham Pharmacia’s drug discovery services team.


John Stuelpnagel, senior vice president, chief operating officer, and general manager for arrays at Illumina, will shift to a part-time status in April and will give up his seat on the board of directors, although he will continue to work as an Illumina fellow, the firm said this week.

Illumina also said senior vice president and general manager of sequencing John West will resign his position as of Feb. 1, and current senior vice president and chief financial officer Christian Henry will become acting manager of sequencing.

The management changes were announced in conjunction with a reorganization of its business into two divisions, one focused on life sciences research and the other on diagnostics. The firm noted that it has already has hired two new general managers to oversee the divisions, but it has not disclosed their names.



Codon Devices has named David Smith to be vice president of operations. In his new position, Smith will oversee the company’s manufacturing, process development, quality, and operations organizations. The company said Smith has worked for 15 years in manufacturing, technology transfer, R&D, and quality control.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.